Trilaciclib Injection [Cosela] Clinical Trials
3 recruitingDrug
Phase 22
Showing 1–3 of 3 trials
Recruiting
Phase 2
A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using Trilaciclib
Ewing SarcomaMyelosuppression
Fudan University22 enrolled1 locationNCT06699472
Recruiting
Trilaciclib for the Prevention of Chemoradiotherapy-Induced Myelosuppression in Esophageal Squamous Cell Carcinoma
ESCC
The First Affiliated Hospital with Nanjing Medical University200 enrolled1 locationNCT06698692
Recruiting
Phase 2
Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy in the Treatment of Esophageal Cancer
Esophageal Cancer
The First Affiliated Hospital with Nanjing Medical University60 enrolled1 locationNCT06569459